Status: current, Defined. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4696212014 | Dolutegravir- and lamivudine- and tenofovir-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
4696213016 | Product containing dolutegravir and lamivudine and tenofovir (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dolutegravir- and lamivudine- and tenofovir-containing product | Is a | Tenofovir-containing product | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product | Is a | Dolutegravir- and lamivudine-containing product | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Dolutegravir- and lamivudine- and tenofovir-containing product | Has active ingredient | Lamivudine | true | Inferred relationship | Some | 1 | |
Dolutegravir- and lamivudine- and tenofovir-containing product | Has active ingredient | Tenofovir | true | Inferred relationship | Some | 2 | |
Dolutegravir- and lamivudine- and tenofovir-containing product | Has active ingredient | Dolutegravir | true | Inferred relationship | Some | 3 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Dolutegravir and lamivudine and tenofovir only product | Is a | True | Dolutegravir- and lamivudine- and tenofovir-containing product | Inferred relationship | Some | |
Dolutegravir- and lamivudine- and tenofovir-containing product in oral dose form | Is a | True | Dolutegravir- and lamivudine- and tenofovir-containing product | Inferred relationship | Some |
This concept is not in any reference sets